BeOne Medicines Ltd.
ONCNASDAQHealthcare● Active
$269.08
$-1.02(-0.38%)
Market Cap$28.8B
P/E Ratio—
52W High$385.22
52W Low$239.25
BeOne Medicines Ltd. (ONC) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ONC · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $5.34B | $3.81B | $2.46B | $1.42B | $1.18B |
| Cost of Revenue | $0.67B | $0.59B | $0.38B | $0.29B | $0.16B |
| Gross Profit | $4.67B | $3.22B | $2.08B | $1.13B | $1.01B |
| Gross Margin %(computed) | 87.49% | 84.41% | 84.55% | 79.77% | 85.98% |
| Operating Expenses | |||||
| R&D Expenses | $2.15B | $1.95B | $1.78B | $1.64B | $1.46B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $4.23B | $3.78B | $3.29B | $2.92B | $2.45B |
| Operating Income | $0.45B | ($0.57B) | ($1.21B) | ($1.79B) | ($1.44B) |
| Operating Margin %(computed) | 8.37% | -14.91% | -49.12% | -126.40% | -122.31% |
| Interest Income | $0.07B | $0.05B | $0.07B | $0.05B | $0.02B |
| Interest Expense | $0.06B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.42B | ($0.53B) | ($0.83B) | ($1.96B) | ($1.44B) |
| Income Tax Expense | $0.13B | $0.11B | $0.06B | $0.04B | $0.02B |
| Net Income | $0.29B | ($0.64B) | ($0.88B) | ($2.00B) | ($1.46B) |
| Net Margin %(computed) | 5.37% | -16.92% | -35.86% | -141.52% | -123.93% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $33.80 | $-6.12 | $-8.45 | $-19.37 | $-15.21 |
| Wtd Avg Shares | 0.11B | 0.11B | 0.10B | 0.10B | 0.09B |
| EBITDA | $0.62B | ($0.40B) | ($1.12B) | ($1.72B) | ($1.39B) |
| EBITDA Margin %(computed) | 11.54% | -10.40% | -45.55% | -121.71% | -118.36% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more BeOne Medicines Ltd. data
About BeOne Medicines Ltd. (ONC) Income Statement
BeOne Medicines Ltd. (ONC) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ONC reported revenue of $5.34B, gross profit of $4.67B (gross margin 87.49%), and net income of $0.29B — a net profit margin of 5.37%.
Frequently asked questions
ONC · 4 questionsBeOne Medicines Ltd. (ONC) reported revenue of $5.34B for 2025, up 40.2% year-over-year.
ONC revenueONC salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08